Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Arecor Therapeutics PLC ( (GB:AREC) ) has shared an announcement.
Arecor Therapeutics has announced the appointment of Singer Capital Markets Advisory LLP as its Nominated Advisor and Joint Broker. This strategic move is expected to strengthen Arecor’s market presence and potentially enhance its operational capabilities, reflecting a proactive approach to navigating the biopharmaceutical industry’s competitive landscape.
More about Arecor Therapeutics PLC
Arecor Therapeutics plc is a globally focused biopharmaceutical company dedicated to transforming patient care by enhancing existing therapeutic products. The company utilizes its proprietary Arestat™ technology platform to develop an internal portfolio of proprietary products, primarily targeting diabetes and other medical indications. Arecor also collaborates with leading pharmaceutical and biotechnology companies to deliver innovative therapeutic solutions.
YTD Price Performance: 0.68%
Average Trading Volume: 8,154
Technical Sentiment Consensus Rating: Hold
Current Market Cap: £27.94M
Find detailed analytics on AREC stock on TipRanks’ Stock Analysis page.
